Home › Funds › OXFORD ASSET MANAGEMENT LLP › ABUS

OXFORD ASSET MANAGEMENT LLP position in ABUS

ARBUTUS BIOPHARMA CORP · Health Care

OXFORD ASSET MANAGEMENT LLP reported holding 939,043 shares of ABUS (ARBUTUS BIOPHARMA CORP) in its Q3 2026 13F filing — a position valued at US$4.5M, representing 2.57% of its reported portfolio and ranking #2 among its reported holdings. OXFORD ASSET MANAGEMENT LLP has disclosed ABUS holdings in 3 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)939.04K sh
Reported value held$4.49M
Portfolio Weight2.57%
First reportedQ2 2025
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How OXFORD ASSET MANAGEMENT LLP's ABUS position evolved

OXFORD ASSET MANAGEMENT LLP first disclosed a stake in ABUS in Q2 2025 at 12,143 shares (US$38K). The position peaked in Q3 2026 at 939,043 shares, worth US$4.5M. Across 3 filings, OXFORD ASSET MANAGEMENT LLP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 939,043 shares valued at US$4.5M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 12.14K $37.52K New
Q4 2025 21.63K $104.05K New
Q3 2026 939.04K $4.49M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABUS and 13F data

ABUS (ARBUTUS BIOPHARMA CORP) is a Health Care company. 36 other funds we track also report a position in ABUS — the largest reported positions include Whitefort Capital Management, LP (US$75.8M), Two Seas Capital LP (US$38.9M), BlackBarn Capital Partners LP (US$10.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABUS

All ABUS fund holders →

FAQ

How long has OXFORD ASSET MANAGEMENT LLP held ABUS?

OXFORD ASSET MANAGEMENT LLP has disclosed ABUS holdings in 3 of the last 6 reported quarters, going back to Q2 2025.

What is OXFORD ASSET MANAGEMENT LLP's current position in ABUS?

As of Q3 2026, OXFORD ASSET MANAGEMENT LLP holds 939.04K shares of ABUS (ARBUTUS BIOPHARMA CORP), valued at $4.49M, representing 2.57% of its reported portfolio and ranking #2.

Has OXFORD ASSET MANAGEMENT LLP been buying or selling ABUS?

In the latest 13F filing (Q3 2026), OXFORD ASSET MANAGEMENT LLP newly opened its position in ABUS. The position peaked in Q3 2026 at 939.04K shares.

Which other funds hold ABUS?

Other major institutional holders of ABUS include Whitefort Capital Management, LP, Two Seas Capital LP, BlackBarn Capital Partners LP, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.